Skip to main content
NeuronFeed Submit a startup

Anagram Therapeutics · Other

Developing novel orally delivered enzyme therapeutics engineered for rare and life-threatening malabsorption diseases.

Amount

$250M

Round

Other

Valuation

Announced

May 2024

Investors

Notes

auto-discovered via firecrawl

📎 Source